Jummai Apata, MBBS, DrPH

Epidemiologist
Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U. S. Food and Drug Administration

Poster(s):

• (141) Assessing Exposure to Recently Approved Medications to Inform Feasibility for Signal Identification Analyses in the FDA’s Sentinel System
  Wednesday, August 28, 2024

  8:00 AM – 1:30 PM CEST